The Carolina BioOncology Institute (CBI) mission is to provide the highest level of comprehensive and quality medical care to cancer patients.

CBI will maintain the highest level of professional, ethical, and regulatory conduct in patient care and clinical research.  All completed research trials conducted through CBI will be published in a national clinical trial registry for public access.

CBI will provide early phase research access to investigational drugs on clinical trials, including cellular, immune, radiologic, and gene transfer studies. 

CBI will utilize electronic medical records (EMR) to minimize errors, maximize efficiency, and to accelerate drug development by embedding clinical trials for real-time data collection and safety monitoring.

CBI will seek to develop strategic partners in the biopharmaceutical industry towards providing cancer patients in our community with unmatched access to the drug development pipeline.

CBI and it’s partners will seek to develop a BioInformatics infrastructure for tumor banking and clinical data ware-housing for drug target discovery, systems biology, and genomic personalized medicine. 

CBI and it’s partners will seek to develop a human applications laboratory (HAL) and cell processing facility for tumor harvesting and culture, leukapheresis and immune cell expansion towards the development of personalized tumor immunotherapy. 

CBI will seek to develop an EMR network of oncologist/investigators for clinical trials.

CBI will seek to educate and train qualified professionals in the multi-disciplinary fields of BioOncology, BioInformatics, clinical research and personalized medicine.